Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04709939 · ClinicalTrials.gov registry record

Mobile-health Approach to Gather Clinical Information From Patients Following Hospital Discharge

A clinical trial of Outpatient Parenteral Antibiotic Therapy, sponsored by University of Iowa.

Completed
Registry status
97
Enrollment target
1
Study location

NCT04709939: Completed study of Outpatient Parenteral Antibiotic Therapy, sponsored by University of Iowa.

NCT04709939 is a study of Outpatient Parenteral Antibiotic Therapy that has completed, run by University of Iowa. The registered enrollment target is 97 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04709939, a study of Outpatient Parenteral Antibiotic Therapy, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
97 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the feasibility of using a mobile-health approach to gather clinical data from patients following discharge from the hospital on outpatient parenteral antibiotic therapy (OPAT). The study population will consist of adult participants who have a smartphone that is capable of both text messaging and pairing with a Bluetooth thermometer that will be provided. Following discharge, patients will be asked to respond to two daily text messages. They will also be reminded to take and send in photos of any skin rashes that may develop as well as their PICC-line site during dressing changes. Text messages will be sent for up to 30 days, but will be stopped sooner if the patient is readmitted to the hospital or if OPAT is discontinued. At the end of the 30 days, all patients will be sent a text message survey about usability, the time it took to complete the study tasks, suggestions for future improvements, and whether they would be willing to be interviewed via phone. A subset of the participants will be interviewed via phone to obtain more detailed feasibility data. Information from the patient's medical record will be collected at the time of hospital discharge as well as at the end of the study period. Additionally, a focus group (via conference call) will be conducted with all research team members and infectious disease physicians involved in OPAT who did not use the system to gauge their needs and to get ideas for future applications of our tools.

Primary Outcome

The number of days that participants submit a temperature reading during the course of the study.

Interventions

  • OTHER Focus Group
  • OTHER OPAT

Study Locations (1)

Iowa

  • University of Iowa Hospitals & Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2021-08-27
Est. Completion 2022-11-19
University of Iowa

228 total trials

What the finished NCT04709939 record still lists

NCT04709939 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.

The record links to 1 condition, with Outpatient Parenteral Antibiotic Therapy appearing as the primary indexed condition, and to 2 interventions - of which Focus Group is the first listed.

NCT04709939 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT04709939 about?

NCT04709939 is a clinical study titled "Mobile-health Approach to Gather Clinical Information From Patients Following Hospital Discharge". The purpose of this study is to assess the feasibility of using a mobile-health approach to gather clinical data from patients following discharge from the hospital on outpatient parenteral antibiotic therapy (OPAT). The study population will consist of adult participants who have a smartphone that ...

What is the current status of trial NCT04709939?

This trial is currently completed. The enrollment target is 97 participants. The study started on 2021-08-27. Estimated completion is 2022-11-19.

What conditions does trial NCT04709939 study?

This clinical trial studies the following conditions: Outpatient Parenteral Antibiotic Therapy.

What interventions are being tested in trial NCT04709939?

The interventions under investigation include: Focus Group (OTHER), OPAT (OTHER).

Who is sponsoring clinical trial NCT04709939?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04709939 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03948490 · 97 participants · NA

    Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas

  • NCT04140487 · 97 participants · Phase 1

    Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

  • NCT04196413 · 97 participants · Phase 1

    GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

  • NCT05223816 · 97 participants · Phase 2

    An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04709939, the US trial registry maintained by the National Library of Medicine. NCT04709939 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.